TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3) Antibody (FITC)

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx337938

Description

TAB3 Antibody (FITC) is a Rabbit Polyclonal against TAB3.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3)
Immunogen: Recombinant Human TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 protein (361-712AA).
Host
Rabbit
Reactivity
Human
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q8N5C8
Gene ID
257397
Background
Antibody anti-TAB3
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products
EH2244
Human TAB3 (TGF-beta-activated kinase 1 and MAP3K7-binding protein 3) ELISA Kit
Ver Producto
FNab10439
TAB3 antibody
Adapter linking MAP3K7/TAK1 and TRAF6 or TRAF2. Mediator of MAP3K7 activation, respectively in the IL1 and TNF signaling pathways. Plays a role in activation of NF-kappa-B and AP1 transcription factor. Isoform 2 may be an oncogenic factor.
Ver Producto
P0226
Recombinant Human TAB3
Ver Producto